Science Lessons What The Business Of Biotech Taught Me About Management Gordon M Binder by Gordon M. Binder, Philip Bashe 9781591398615, 1591398614 instant download after payment.

Under Gordon Binder's leadership, Amgen became the world's largest and most successful biotech company in the world. This text describes what it really takes to manage risk, financing, creative employees, and intellectual property on the international stage.Here’s what not to say when a senior partner of San Francisco’s
most prominent law firm calls to recommend that you interview for
the chief financial officer position at a fledgling outfit called Amgen.“Amgen? What’s Amgen?”“It’s a biotechnology company We represent them.”I nearly blurted, “What’s biotechnology?”—not an unreasonable
question in 1982.The biotech industry, barely a decade old, had yet to
market a single drug. My twenty years in the business world had been
spent almost exclusively at major corporations like Litton Industries
and Ford Motor Company. The comparatively small System Development Corporation (SDC), where I served as vice president of finance for ten years, supported a workforce of roughly four thousand.Now, at age forty-six, did I really want to get involved in a start¬up operation with only a few dozen employees and no products even
remotely on the horizon? Probably not.